East Hanover, NJ, United States of America

Colleen Patricia Serafin


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Colleen Patricia Serafin: Innovator in Inhaler Technology

Introduction

Colleen Patricia Serafin is a notable inventor based in East Hanover, NJ (US). She has made significant contributions to the field of inhaler technology, particularly with her innovative design of a multidose inhaler. Her work is aimed at enhancing user experience and improving medication delivery systems.

Latest Patents

Colleen holds 1 patent for her invention of a multidose inhaler. This inhaler features a durable unit and a replaceable cartridge unit, designed to provide an 'open-inhale-close' user experience. The durable unit includes a breath-actuated trigger mechanism and may also incorporate electronics for user feedback and telehealth capabilities. The replaceable unit consists of a mouthpiece, blister strip, aerosol path dose counter, and a blister piercing and aerosolization engine assembly. Additionally, a lockout mechanism is included to prevent further use of the cartridge once the dose counter reaches a preselected limit.

Career Highlights

Colleen is currently employed at Novartis AG, where she continues to develop innovative solutions in the pharmaceutical industry. Her work focuses on improving inhalation devices, which are crucial for patients requiring respiratory medication.

Collaborations

Throughout her career, Colleen has collaborated with notable colleagues such as Mark Glusker and Alex Yulan Chiao. These partnerships have contributed to her success and the advancement of inhaler technology.

Conclusion

Colleen Patricia Serafin is a pioneering inventor whose work in multidose inhalers is making a significant impact in the healthcare sector. Her innovative designs are set to improve the lives of many patients who rely on inhalation therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…